Number of Shares
29,507.00
Current Holdings Value*
kr2.05 Mil
% of Portfolio
0.68%
Total Estimate Gain
kr3.00 Mil
% of Total Estimate Gain
11.34%

AZL DFA International Core Equity Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST held 29,507.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr2.05 Mil. This investment constitutes 0.68% of their stock portfolio, and ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. And since then AZL DFA International Core Equity Fund has made 3 purchases of OCSE:NOVO B, at an average price of kr444.84, for a total of 59,414.00 shares. In addition, there have been 5 sales at an average price of kr565.72 for 29,907.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, AZL DFA International Core Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr3.00 Mil, reflecting a 11.34% gain to date.

AZL DFA International Core Equity Fund OCSE:NOVO B (kr423.90) Holding Chart

AZL DFA International Core Equity Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1